News & Perspective

Jun 05, 2019

Jun 05, 2019

News Scan for Jun 05, 2019

Hospital superbugs in Tuscany
Universal flu vaccine trial
Cholera vaccine storage

Sep 12, 2018

Sep 12, 2018

News Scan for Sep 12, 2018

Nigeria assist for UK monkeypox
Measles and public health cuts
Global Fund disease progress
Seqirus cell-based flu vaccine

May 27, 2015

May 27, 2015

News Scan for May 27, 2015

Immune response to flu vaccine
Caramel apple Listeria source
Measles, rubella in Europe
Fast drug-resistance test

Dec 02, 2009

Dec 02, 2009

Another seasonal flu vaccine on way to US market

(CIDRAP News) – A second seasonal influenza vaccine made by Novartis was approved recently by the US Food and Drug Administration (FDA), and the company said some doses may reach the market this flu season.

Aug 06, 2008

Aug 06, 2008

FDA approvals clear way for flu vaccine marketing

Editor's note: This story was updated Aug 7 to include information about the start of influenza vaccine shipments by Novartis.

(CIDRAP News) – The six companies that make influenza vaccine for the US market have won federal approval for their version of this year's vaccine, in which all three flu strains used in last year's product have been replaced, the Food and Drug Administration (FDA) announced yesterday.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»